Please assess the completion status of the following clinical trial:

Trial Title: Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. RT-PCR proven SARS-CoV-2 infection or computed tomography scan findings compatible with the COVID19 disease (bilateral multifocal ground-glass opacities ≥50%)~2. Moderate to severe COVID-19 defined by PFR ratio of \<200~3. SOFA score\>4~4. Patients with vitamin D deficiency defined as 25 (OH)D level\<20 ng/ml~5. Age\>18 years~Exclusion Criteria:~* 1. Vitamin D sufficient or already receiving vitamin D supplements 2. Active malignancy 3. Hypercalcemia, hyperparathyroidism 4. Chronic kidney disease (eGFR\<30 ml/min) 5. Pregnant and lactating women 6. Patient on mechanical ventilation at ICU admission

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Intervention (Type: EXPERIMENTAL): Vitamn D 6 lakh IU oral stat
- Placebo (Type: PLACEBO_COMPARATOR): Placebo equal volume/ weight

Based on this trial design, predict the completion outcome and termination type (if applicable).